ArticleScientific reports2025
Multimodal dual-stage feature refinement for robust skin lesion classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Hybrid Vision Transformer-CNN Architecture with Optimized Feature Selection for Skin Cancer Classification.Diagnostics (Basel, Switzerland) · 2026Article
- Few-shot skin lesion classification with Adaptive Multi-Scale Convolutional Attention Network.PloS one · 2026Article
- Interpretable multimodal fusion for skin lesion classification using dermoscopic images and patient metadata.Frontiers in medicine · 2026Article
- OFS: on fused SAMI filtered handcraft and DSRSENet features for enhanced skin malignancy detection.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer continues to pose a formidable global health challenge, where expedient detection is paramount to diminishing mortality. However, the inherent heterogeneity of skin lesions, exacerbated by class imbalance, frequently undermines automated classification efforts, particularly in unconstrained environments such as smartphone imagery that lacks dermoscopic clarity. In this research, we present DualRefNet, a novel multimodal deep learning paradigm that employs a dual-stage feature refinement strategy. First, an auxiliary super-resolution task augments visual representations; subsequently, a class-frequency-based regularization of the final fully connected layers refines the fused features, thus mitigating errors induced by high intra-class and low inter-class variability. Concurrently, a weighted cross-entropy loss deftly addresses class imbalance. Empirical evaluations on the PAD-UFES20 and ISIC-2019 datasets demonstrate balanced accuracies of 0.845 and 0.815, respectively, attesting to DualRefNet’s prowess under varied conditions. Furthermore, the confusion matrix and class-wise analyses highlight its equitable performance across all categories, rendering it a potential candidate for widespread, resource-constrained deployments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.